Drug Shortage Report for NAROPIN
Report ID | 130813 |
Drug Identification Number | 02229418 |
Brand name | NAROPIN |
Common or Proper name | Naropin (ropivacaine HCl 10mg/mL 5x10mL SU Polyamp® Duofit®) |
Company Name | ASPEN PHARMACARE CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL EPIDURAL |
Packaging size | 5 PP Polybag |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-01-04 |
Estimated end date | Unknown |
Actual end date | 2021-08-01 |
Shortage status | Resolved |
Updated date | 2021-09-03 |
Company comments | n/a |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | UNIT 8, 1155 NORTH SERVICE ROAD WEST OAKVILLE, ONTARIO CANADA L6M 3E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-09-03 | French | Compare |
v5 | 2021-09-03 | English | Compare |
v4 | 2021-01-05 | English | Compare |
v3 | 2021-01-04 | French | Compare |
v2 | 2021-01-04 | English | Compare |
v1 | 2021-01-04 | English | Compare |
Showing 1 to 6 of 6